Lakewood-Amedex Biotherapeutics Inc.
Lakewood-Amedex Biotherapeutics Inc.
No insider data available
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|
Related Party | - | 0 | |||||
Assets | |||||||
Assets Current | |||||||
Cash And Cash Equivalents At Carrying Value | 3 | 0 | |||||
Prepaid Expense And Other Assets Current | 0 | 0 | |||||
Assets Current | 5 | 0 | |||||
Operating Lease Right Of Use Asset | 0 | 0 | |||||
Property Plant And Equipment Net | 0 | 0 | |||||
Other Assets Noncurrent | 0 | 0 | |||||
Assets | 5 | 0 | |||||
Liabilities And Stockhold… | |||||||
Liabilities Current | |||||||
Accounts Payable Current | 0 | 1 | |||||
Accounts Payable And Other Accrued Liabilities Cur… | 0 | 1 | |||||
Operating Lease Liability Current | 0 | 0 | |||||
Liabilities Current | 1 | 3 | |||||
Operating Lease Liability Noncurrent | - | 0 | |||||
Liabilities | 1 | 3 | |||||
Stockholders Equity | |||||||
Common Stock Value | 0 | 0 | |||||
Additional Paid In Capital | 73 | 52 | |||||
Retained Earnings Accumulated Deficit | -69 | -54 | |||||
Treasury Stock Value | -0 | -0 | |||||
Stockholders Equity | 4 | -3 | |||||
Liabilities And Stockholders Equity | 5 | 0 | |||||
Series A Convertible Preferred Stock | - | 0 | |||||
Series B Convertible Preferred Stock | - | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | |||||
Common Stock Shares Authorized | 13 | 125 | |||||
Common Stock Shares Issued | 2 | 7 | |||||
Shares Outstanding | 2 | 7 | |||||
Treasury Stock Common Shares | 0 | 0 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month |
|---|---|---|---|---|---|---|
| 2026 | 8.45% | -63.24% | -68.73% | - | - | - |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Lakewood-Amedex Biotherapeutics Inc. (LABT) — SEC Financial Statements & Analysis
Lakewood-Amedex Biotherapeutics Inc. (LABT) is a pharmaceutical preparations company, incorporated in NV. Lakewood-Amedex Biotherapeutics Inc. trades on Nasdaq as: LABT. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Lakewood-Amedex Biotherapeutics Inc. reported a Debt-to-Equity ratio of 0.15x, a Price-to-Book (P/B) ratio of 1.03x (TTM), at a market cap of $4.46M. Figures below are sourced from SEC EDGAR, as-filed.
- Debt To Equity
- 0.15x
- P/B TTM
- 1.03x
- Market Cap
- $4.46M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Lakewood-Amedex Biotherapeutics Inc. in?
Lakewood-Amedex Biotherapeutics Inc. (LABT) operates in the Pharmaceutical Preparations industry.
What is LABT's market cap?
Lakewood-Amedex Biotherapeutics Inc. (LABT) has a market capitalization of $4.46M as of 2026-06-30.
What exchange does LABT trade on?
Lakewood-Amedex Biotherapeutics Inc. (LABT) trades on the Nasdaq.
Where is Lakewood-Amedex Biotherapeutics Inc. incorporated?
Lakewood-Amedex Biotherapeutics Inc. is incorporated in NV.